#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16934	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2179	762.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1447	1447	C	1002	C,A	973,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30232	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3666	809.1	0	.	n	.	0	A20C	SNP	20	20	A	432	432	C	552	C,A	528,16	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30232	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3666	809.1	0	.	n	.	0	T695C	SNP	695	695	T	1107	1107	C	1015	C,T	976,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30232	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3666	809.1	0	.	n	.	0	A1638G	SNP	1638	1638	A	2050	2050	G	930	G,A	897,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30232	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3666	809.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2383	2383	C	899	C,T	867,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30232	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3666	809.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2457	2457	A	944	A,C	920,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30232	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3666	809.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3009	3009	C	868	C	838	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1980	folP	855	855	100.0	folP.l15.c4.ctg.1	1465	132.4	1	SNP	p	R229S	1	.	.	685	687	AGC	957	959	AGC	184;185;183	A;G;C	180;180;177	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5454	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3493	153.4	1	SNP	p	S91F	1	.	.	271	273	TTC	627	629	TTC	188;188;192	T;T;C	184;185;189	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5454	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3493	153.4	1	SNP	p	D95G	1	.	.	283	285	GGC	639	641	GGC	181;178;180	G;G;C	176;171;175	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5454	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3493	153.4	1	SNP	p	G95N	0	.	.	283	285	GGC	639	641	GGC	181;178;180	G;G;C	176;171;175	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1806	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1347	131.5	1	SNP	p	G45D	0	.	.	133	135	GGC	507	509	GGC	238;237;238	G;G;C	231;228;230	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	876	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c4.ctg.1	989	87.1	0	.	n	.	0	G98A	SNP	98	98	G	511	511	A	196	A,G	184,7	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	876	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c4.ctg.1	989	87.1	0	.	n	.	0	A197.	DEL	197	197	A	609	609	A	228	A	221	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5252	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2908	176.9	1	SNP	p	D86N	0	.	.	256	258	GAC	581	583	GAC	193;193;195	G;A,C;C	188;185,1;188	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5252	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2908	176.9	1	SNP	p	S87R	1	.	.	259	261	CGT	584	586	CGT	196;196;199	C,T;G;T	189,1;190;190	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5252	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2908	176.9	1	SNP	p	R87I	0	.	.	259	261	CGT	584	586	CGT	196;196;199	C,T;G;T	189,1;190;190	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5252	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2908	176.9	1	SNP	p	R87W	0	.	.	259	261	CGT	584	586	CGT	196;196;199	C,T;G;T	189,1;190;190	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5252	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2908	176.9	1	SNP	p	S88P	0	.	.	262	264	TCC	587	589	TCC	194;197;196	T;C;C	186;188;186	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4496	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2514	175.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1457	1459	GGC	211;209;205	G;G,C;C,A	205;202,1;199,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4454	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2404	181.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1362	1364	GCA	249;252;254	G;C;A,C	239;243;247,1	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4454	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2404	181.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1365	1367	ATC	252;253;250	A,C;T;C	243,1;247;241	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4454	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2404	181.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1377	1379	GTG	240;242;247	G;T;G	238;238;243	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4454	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2404	181.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1377	1379	GTG	240;242;247	G;T;G	238;238;243	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4454	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2404	181.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1881	1883	ACC	185;189;190	A;C;C	171;180;181	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4454	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2404	181.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1935	1937	GCG	187;187;187	G;C,G;G	171;163,3;176	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4454	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2404	181.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1935	1937	GCG	187;187;187	G;C,G;G	171;163,3;176	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4454	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2404	181.1	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2058	2060	AGC	164;164;160	A;G;C	158;157;153	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4454	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2404	181.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2067	2069	GGC	166;166;165	G;G;C	157;156;155	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4454	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2404	181.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2085	2087	CCG	127;128;130	C,G;CG,CGG;G	105,6;101,1;110	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6370	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3007	207.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1583	1585	CCG	236;236;233	C;C;G	222;227;221	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2416	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1721	137.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	522	522	C	172	C	166	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3176	porB1b	1047	1047	98.76	porB1b.l15.c30.ctg.1	1486	209.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	406	408	GAA	225;225;228	G;A;A	221;220;221	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3176	porB1b	1047	1047	98.76	porB1b.l15.c30.ctg.1	1486	209.8	0	.	p	.	0	K41D	NONSYN	121	123	AAA	415	417	GAC	223;222;222	G;A;C,A	217;216;212,4	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3176	porB1b	1047	1047	98.76	porB1b.l15.c30.ctg.1	1486	209.8	0	.	p	.	0	K120N	NONSYN	358	360	AAG	652	654	AAT	250;250;254	A;A;T,G	248;246;240,6	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3176	porB1b	1047	1047	98.76	porB1b.l15.c30.ctg.1	1486	209.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	817	819	TCA	251;252;253	T;C;A	237;241;243	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3176	porB1b	1047	1047	98.76	porB1b.l15.c30.ctg.1	1486	209.8	0	.	p	.	0	A218V	NONSYN	652	654	GCC	946	948	GTC	264;263;263	G,A;T;C	254,1;250;255	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3176	porB1b	1047	1047	98.76	porB1b.l15.c30.ctg.1	1486	209.8	0	.	p	.	0	A242V	NONSYN	724	726	GCC	1018	1020	GTT	251;246;245	G;T,C;T,C	243;233,5;231,5	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3176	porB1b	1047	1047	98.76	porB1b.l15.c30.ctg.1	1486	209.8	1	SNP	p	A121D	1	.	.	361	363	GAC	655	657	GAC	255;256;254	G,A;A;C	244,4;244;247	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3176	porB1b	1047	1047	98.76	porB1b.l15.c30.ctg.1	1486	209.8	1	SNP	p	D121N	0	.	.	361	363	GAC	655	657	GAC	255;256;254	G,A;A;C	244,4;244;247	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11260	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4893	226.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1230	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1078	111.8	1	SNP	p	V57M	1	.	.	169	171	ATG	595	597	ATG	249;252;252	A;T,G;G	241;240,1;239	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
